FDA’s new playbook: Lots of media announcements but not much rulemaking
Almost as surprising as the agency’s shift away from rulemaking is the fact that the powerful companies FDA regulates have put up little resistance.
Original Source
Read the full article at Courthousenews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.